Ping An Biomedical Co., Ltd. PASW
Nasdaq · stock · Apparel & Other Finishd Prods of Fabrics & Similar Matl · website · IPO 2025-07-18
Ping An Biomedical Co., Ltd. financials (annual)
Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $4.8M | $87.6M |
| Gross profit | $133,376 | $5.4M |
| Operating income | -$2.1M | -$2,039 |
| Income tax | $260,653 | -$601,456 |
| Net income | -$1.8M | -$1.3M |
| EPS (diluted) | $-0.10 | $-0.07 |
| Operating cash flow | -$902,902 | $14.6M |
| Cash & equivalents | $164,697 | $130,923 |
| Inventory | $62,074 | $127,296 |
| Total assets | $9.6M | $56.8M |
| Total liabilities | $3.3M | $64.0M |
| Shareholders' equity | $6.4M | -$7.2M |
Growth · year-over-year · Revenue CAGR -94.5%
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue growth | -94.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.